141 related articles for article (PubMed ID: 21206334)
21. Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-two case reports.
Hegade VS; Sood R; Saralaya D; Moreea S
Ann Hepatol; 2013; 12(4):629-33. PubMed ID: 23813142
[TBL] [Abstract][Full Text] [Related]
22. Concurrent acute interstitial pneumonia and pulmonary embolism during treatment with peginterferon alpha-2a and ribavirin in a patient with hepatitis C.
Coban H; Yahyaoglu M; Vatan MB
Indian J Pharmacol; 2014; 46(4):443-5. PubMed ID: 25097288
[TBL] [Abstract][Full Text] [Related]
23. Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b.
Venezia G; Licata A; Di Marco V; Craxì A; Almasio PL
Dig Liver Dis; 2005 Nov; 37(11):882-5. PubMed ID: 16169301
[TBL] [Abstract][Full Text] [Related]
24. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
[TBL] [Abstract][Full Text] [Related]
25. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus treatment with pegylated interferon-alfa therapy leading to generalized interstitial granuloma annulare and review of the literature.
Ahmad U; Li X; Sodeman T; Daboul I
Am J Ther; 2013; 20(5):585-7. PubMed ID: 21317616
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
28. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
[TBL] [Abstract][Full Text] [Related]
29. Management of hepatitis C.
Smith C
Minn Med; 2003 Jun; 86(6):53-6. PubMed ID: 12834215
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of hepatitis C treatment with pegylated interferons and ribavirin.
Jiménez-Méndez R; Castañeda-Hernández G
Ann Hepatol; 2010; 9 Suppl():61-4. PubMed ID: 20713998
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C treatment, HAART and side effects.
TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
[No Abstract] [Full Text] [Related]
32. Individualized extension of pegylated interferon plus ribavirin therapy for recurrent hepatitis C genotype 1b after living-donor liver transplantation.
Ueda Y; Takada Y; Marusawa H; Egawa H; Uemoto S; Chiba T
Transplantation; 2010 Sep; 90(6):661-5. PubMed ID: 20110853
[TBL] [Abstract][Full Text] [Related]
33. Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon.
Arizcorreta A; Brun F; Fernández-Gutiérrez C; García Juárez R; Guerrero F; Pérez-Guzmán E; Girón-González JA
Clin Microbiol Infect; 2004 Dec; 10(12):1067-74. PubMed ID: 15606633
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.
Huang CF; Yang JF; Dai CY; Huang JF; Hou NJ; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL; Yu ML
J Infect Dis; 2010 Mar; 201(5):751-9. PubMed ID: 20102281
[TBL] [Abstract][Full Text] [Related]
35. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
[No Abstract] [Full Text] [Related]
36. [A case of renal cell carcinoma complicated with interstitial pneumonitis, complete A-V block and pleural effusion during interferon-alpha therapy].
Tsushima K; Yamaguchi S; Furihata K; Hotta J; Sasabayashi M; Urushihata K; Takashi S; Tsukadaira A; Yamazaki Y; Satou E; Hanaoka M; Koizumi T; Fujimoto K; Ohkubo Y; Kubo K
Nihon Kokyuki Gakkai Zasshi; 2001 Nov; 39(11):893-8. PubMed ID: 11855092
[TBL] [Abstract][Full Text] [Related]
37. Adult respiratory distress syndrome after treatment with pegylated interferon alpha-2a and ribavirin.
Vartany E; Caldwell CA; Trow TK
Heart Lung; 2008; 37(2):153-6. PubMed ID: 18371508
[TBL] [Abstract][Full Text] [Related]
38. Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort study.
Lang JP; Melin P; Ouzan D; Rotily M; Fontanges T; Marcellin P; Chousterman M; Cacoub P;
Antivir Ther; 2010; 15(4):599-606. PubMed ID: 20587853
[TBL] [Abstract][Full Text] [Related]
39. Interferon for hepatitis C patients with psychiatric disorders.
Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF
Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920
[No Abstract] [Full Text] [Related]
40. Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C.
Aghemo A; Rumi MG; Colombo M
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):925-35. PubMed ID: 19803700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
